Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Organometallic complexes with antiestrogenic and antiproliferative effects

Feb. 20, 2001

Antiangiogenic/antitumor compound TSRI-265 specifically disrupts MMP-2 binding to alphavbeta3

Feb. 20, 2001

KS Biomedix and Aurelium BioPharma enter proteomics alliance

Feb. 20, 2001

MAGE-12 T-cell epitope available for licensing from NIH

Feb. 20, 2001

Available for licensing from NIH: T-cell epitopes from NY-ESO-1 cancer antigen

Feb. 20, 2001

Cyclacel to evaluate lead CDK2 inhibitor in phase I

Feb. 19, 2001

AEterna enters two commercialization alliances for Neovastat in Europe

Feb. 19, 2001

EntreMed expands phase II 2ME2 program to include prostate cancer

Feb. 19, 2001

GenVec begins phase I clinical trial with TNFerade

Feb. 16, 2001

Merck's new oligopeptide-cytotoxic agent conjugates useful for Rx of cancer, BPH

Feb. 16, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 30, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...